Youlief 3N EyeSolution

Manufacturer
Plcoskin | Shinsegae Intercos Korea Inc.
Effective date
2020-01-27
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:03:29

Label at a glance#

ProductYoulief 3N EyeSolution
Active ingredientHIBISCUS SYRIACUS BARK, ADENOSINE, GINGER
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Adenosine, ginger root extract, hibiscus syriacus bark extract

INACTIVE INGREDIENT SECTION

WATER, BUTYLENE GLYCOL, GLYCERIN,
PROPANEDIOL, DIGLYCERIN,
1,2-HEXANEDIOL, GLYCERETH-25
PCA ISOSTEARATE, CAFFEINE,
HYDROXYETHYLCELLULOSE, CAPRYLYL
GLYCOL, CARBOMER, TROMETHAMINE,
ETHYLHEXYLGLYCERIN, *ADENOSINE,
ACETYL GLUCOSAMINE, DISODIUM EDTA,
SODIUM HYALURONATE, BETA-GLUCAN,
HYDROLYZED SODIUM HYALURONATE,
HYDROLYZED HYALURONIC ACID,
*LOTUS JAPONICUS SOMATIC EMBRYO
EXTRACT, HYDROXYPROPYLTRIMONIUM
HYALURONATE, *ZINGIBER OFFICINALE
(GINGER) ROOT EXTRACT

OTC - PURPOSE SECTION

anti-wrinkle

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

Every morning and evening, after the usage of ampoules or essences, take a moderate amount of the cosmetics and softly spread along the eye area and parts where wrinkles are considerates then gently pat for the skin to absorb.

WARNINGS SECTION

For external use only
When using this product

■ if the following symptoms occurs after use, stop use and consult with a skin specialist

red specks, swelling, itching

■ don’t use on the part where there is injury, eczema, or dermatitis

Keep out of reach of children

■ if swallowed, get medical help or contact a person control center immediately

DOSAGE & ADMINISTRATION SECTION

for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
GINGER Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
73560-0002-12022-01-28C16284748780-1d6a99b39-ee1f-a426-e053-dadaa90af4c2Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73560-0002-1Youlief 3N EyeSolution15 mL in 1 TUBESOLUTION152

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73560-0002YOULIEF 3N EYESOLUTION (ADENOSINE, GINGER ROOT EXTRACT, HIBISCUS SYRIACUS BARK EXTRACT) SOLUTION [PLCOSKIN]2Legacy NDC, 1 package rows20200128_9d2b0f3b-08bf-7da9-e053-2995a90a29fa.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73560-000273560-0002-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
9d2cf141-b1af-40e9-e053-2995a90acf359d2b0f3b-08bf-7da9-e053-2995a90a29fa2020-01-27WarningsExact identifier
spl id: 9d2cf141-b1af-40e9-e053-2995a90acf35
spl set id: 9d2b0f3b-08bf-7da9-e053-2995a90a29fa

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.